Abstract: A camera module, according to one embodiment, comprises: a lens assembly; a lens driving unit for moving the lens assembly in the direction of the optical axis; a position sensor unit for detecting the position of the lens assembly; and a control unit for, on the basis of the position of the lens assembly detected by the position sensor unit, outputting, to the lens driving unit, a drive signal for moving the lens assembly to a target position, wherein the position sensor unit comprises a plurality of sensor units which have at least one output terminal connected with each other, an amplifier which is commonly connected with the plurality of sensor units, and an analog-digital converter which is connected to the amplifier.

Abstract: According to an embodiment of the present invention, an actuator control apparatus comprises: an actuator changing an optical path of a lens; and a controller controlling the actuator, wherein the actuator comprises a first driver and a second driver which are arranged on a first side of a lens support member, and a third driver and a fourth driver which are arranged on a second side of the lens support member. A first distance between the first driver and the second driver is different from a second distance between the first driver and the third driver, and the first driver and the fourth driver are located in a diagonal direction with respect to each other. The controller applies a first current to the second driver and the third driver and applies a second current to the first driver and the fourth driver. When the lens is moved in a diagonal direction, an absolute value of the first current is different from an absolute value of the second current.

Abstract: Disclosed is a stable pharmaceutical formulation, comprising a fusion protein in which the extracellular ligand-binding domain of a human p75 tumor necrosis factor receptor is fused to the Fc domain of human IgG and a succinate buffering agent, without comprising a stabilizer. The stable pharmaceutical formulation enables the long-term storage of the TNFR-Fc fusion protein formulation and can exhibit superior storage stability without the need for demanding storage conditions, and is a simple formulation because no stabilizer is comprised therein and is thus more economical than other stabilizer-comprising formulations.

Abstract: The present invention relates to a Doherty combiner used in a Doherty power amplifier, the Doherty combiner comprising: a phase shift section connected to one end of a carrier amplifier so as to change a phase of an RF signal output from the carrier amplifier; a matching section connected to an output terminal of the Doherty power amplifier so as to impedance-match an output of the Doherty power amplifier; and a bandwidth improvement section connected to one end of a peaking amplifier so as to change at least one of a phase bandwidth and an amplitude bandwidth of the Doherty power amplifier.

Abstract: A camera device calibration method according to one embodiment comprises the steps of: acquiring first data including location values of a first zoom lens and location values of a first focus lens, corresponding to the location values of the first zoom lens; setting at least two location points of the first zoom lens; acquiring at least two location values, which correspond to the location values of the first focus lens corresponding to at least two location points of the first zoom lens; acquiring second data corresponding to a value between at least two location values of the first zoom lens; and setting, in a camera including the first zoom lens and the first focus lens, at least two location values of the first zoom lens and the first focus lens when a difference value, which is acquired by comparing the first data with the second data, is within a preset threshold range.

Abstract: According to an embodiment of the present invention, in a camera device including first and second cameras, focal position information of the first camera and focal position information of the second camera are matched with each other. Also, the accuracy of the current focal position of the first camera is determined based on the phase difference of images obtained by the first camera when the first camera is auto-focused. Subsequently, when the accuracy of the current focal position of the first camera is low, an accurate focal position of the first camera is tracked by using the matched focal position information of the second camera. As described above, according to the present embodiment, when an auto-focusing function of the first camera is activated, focal position movements are tracked by using the focal position information of the second camera as well as zoom tracking of the first camera, and thus, the accuracy can be improved.

Abstract: A stable liquid pharmaceutical preparation of an anti-influenza virus antibody and, more specifically, a stable liquid pharmaceutical preparation that comprises: (A) an anti-influenza virus antibody or a mixture of two or more different types of anti-influenza virus antibodies; (B) a surfactant; (C) a sugar or a sugar derivative; and (D) an amino acid. The stable liquid pharmaceutical preparation for an anti-influenza virus antibody disclosed herein has excellent storage stability at low temperature (5° C.), room temperature (25° C.), and high temperature (40° C.) and excellent long-term (12 months) storage stability, and may be administered intravenously, intramuscularly, transdermally, subcutaneously, intraperitoneally, topically, or in combinations thereof.

Abstract: A stable liquid pharmaceutical formulation according to the present invention includes an antibody or antigen-binding fragment thereof, a surfactant, a sugar or a sugar derivative, a buffer, and a stabilizer. The stable liquid pharmaceutical formulation according to the present invention has low viscosity not only when antibody content is low but also when antibody content is high, and exhibits superior long-term storage stability based on superior stability observed under accelerated conditions and harsh conditions.

Abstract: A camera module, according to one embodiment, comprises: a lens assembly; a lens driving unit for moving the lens assembly in the direction of the optical axis; a position sensor unit for detecting the position of the lens assembly; and a control unit for, on the basis of the position of the lens assembly detected by the position sensor unit, outputting, to the lens driving unit, a drive signal for moving the lens assembly to a target position, wherein the position sensor unit comprises a plurality of sensor units which have at least one output terminal connected with each other, an amplifier which is commonly connected with the plurality of sensor units, and an analog-digital converter which is connected to the amplifier.

Abstract: Disclosed is a stable liquid formulation, comprising an antibody or antigen-binding portion thereof, an acetate buffer, glycine, and a surfactant, wherein the stable liquid formulation does not comprise at least one of sugar, a sugar alcohol and a metal salt, and the stable liquid formulation is still stable even upon high antibody content, and is superior in osmolality and viscosity, and subcutaneous administration thereof is possible.

Abstract: Disclosed is a stable liquid formulation, comprising an antibody or antigen-binding portion thereof, an acetate buffer, glycine, and a surfactant, wherein the stable liquid formulation does not comprise at least one of sugar, a sugar alcohol and a metal salt, and the stable liquid formulation is still stable even upon high antibody content, and is superior in osmolality and viscosity, and subcutaneous administration thereof is possible.

Abstract: The present invention provides a stable liquid pharmaceutical formulation containing: an antibody or its antigen-binding fragment; a surfactant; a sugar or its derivative; and a buffer. The stable liquid pharmaceutical formulation according to the present invention has low viscosity while containing a high content of the antibody, has excellent long-term storage stability based on excellent stability under accelerated conditions and severe conditions, and may be administered subcutaneously.

Abstract: An electric cooker is configured to cook food in a pressurized state and a non-pressurized state of an inner pot, thereby improving the cooking quality and convenience of use. The electric cooker includes a main body having an inner pot configured to accommodate food and a heating unit; a lid coupled to an upper portion of the main body and opened/closed by an opening/closing unit; and a pressure switching selection unit arranged to pass through the lid and configured to switch or maintain opened/closed states to discharge internal steam from the inner pot by interworking with the opening/closing unit.

Abstract: The present invention relates to a Doherty combiner used in a Doherty power amplifier, the Doherty combiner comprising: a phase shift section connected to one end of a carrier amplifier so as to change a phase of an RF signal output from the carrier amplifier; a matching section connected to an output terminal of the Doherty power amplifier so as to impedance-match an output of the Doherty power amplifier; and a bandwidth improvement section connected to one end of a peaking amplifier so as to change at least one of a phase bandwidth and an amplitude bandwidth of the Doherty power amplifier.

Abstract: Disclosed is a stable liquid formulation, comprising an antibody or antigen-binding portion thereof, an acetate buffer, glycine, and a surfactant, wherein the stable liquid formulation does not comprise at least one of sugar, a sugar alcohol and a metal salt, and the stable liquid formulation is still stable even upon high antibody content, and is superior in osmolality and viscosity, and subcutaneous administration thereof is possible.

Abstract: Disclosed is a stable pharmaceutical formulation, comprising a fusion protein in which the extracellular ligand-binding domain of a human p75 tumor necrosis factor receptor is fused to the Fc domain of human IgG and a succinate buffering agent, without comprising a stabilizer. The stable pharmaceutical formulation enables the long-term storage of the TNFR-Fc fusion protein formulation and can exhibit superior storage stability without the need for demanding storage conditions, and is a simple formulation because no stabilizer is comprised therein and is thus more economical than other stabilizer-comprising formulations.

Abstract: An electric cooker is configured to cook food in a pressurized state and a non-pressurized state of an inner pot, thereby improving the cooking quality and convenience of use. The electric cooker includes a main body having an inner pot configured to accommodate food and a heating unit; a lid coupled to an upper portion of the main body and opened/closed by an opening/closing unit; and a pressure switching selection unit arranged to pass through the lid and configured to switch or maintain opened/closed states to discharge internal steam from the inner pot by interworking with the opening/closing unit.

Abstract: An electronic device includes a first sensor, a camera, and a processor functionally connected to the first sensor and the camera, wherein the processor is configured to acquire a first biometric signal through the first sensor and a second biometric signal through the camera at a first location, acquire a third biometric signal through the first sensor and a fourth biometric signal through the camera at a second location, and determine a blood pressure based on the first biometric signal and the second biometric signal acquired at the first location and the third biometric signal and the fourth biometric signal acquired at the second location.

Abstract: Disclosed is a device for protection a program. The device includes a protection domain unit including an encrypted protection domain, a start point display unit configured to display a start point of the encrypted protection domain, and an end point display unit configured to display an end point of the encrypted protection domain; and a protection domain connection unit including a decryption unit configured to generate a running code unit by decrypting the encrypted protection domain and a protection domain calling unit configured to call the running code unit.

Abstract: Disclosed are: a caster mounted on a teaching aid including a whiteboard, or furniture, etc. so as to conveniently and stably convert between a movement state and a stopping state; and a whiteboard including the caster. The caster is mounted on a pedestal fixed to the lower end of a column frame on which the whiteboard is mounted.